Principal Financial Group Inc. acquired a new stake in shares of Acadia Healthcare Company, Inc. (NASDAQ:ACHC) in the second quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm acquired 312,345 shares of the company’s stock, valued at approximately $15,424,000. Principal Financial Group Inc. owned about 0.36% of Acadia Healthcare at the end of the most recent quarter.

A number of other institutional investors and hedge funds have also recently added to or reduced their stakes in the stock. Nationwide Fund Advisors lifted its position in shares of Acadia Healthcare by 683.9% in the first quarter. Nationwide Fund Advisors now owns 75,852 shares of the company’s stock worth $3,307,000 after buying an additional 66,176 shares during the last quarter. US Bancorp DE lifted its position in shares of Acadia Healthcare by 16.4% in the first quarter. US Bancorp DE now owns 31,740 shares of the company’s stock worth $1,383,000 after buying an additional 4,479 shares during the last quarter. Bank of New York Mellon Corp lifted its position in shares of Acadia Healthcare by 5.4% in the first quarter. Bank of New York Mellon Corp now owns 695,995 shares of the company’s stock worth $30,346,000 after buying an additional 35,566 shares during the last quarter. Suntrust Banks Inc. lifted its position in shares of Acadia Healthcare by 24.9% in the first quarter. Suntrust Banks Inc. now owns 17,362 shares of the company’s stock worth $755,000 after buying an additional 3,461 shares during the last quarter. Finally, UBS Asset Management Americas Inc. lifted its position in shares of Acadia Healthcare by 21.6% in the first quarter. UBS Asset Management Americas Inc. now owns 332,355 shares of the company’s stock worth $14,491,000 after buying an additional 59,001 shares during the last quarter.

Acadia Healthcare Company, Inc. (NASDAQ:ACHC) opened at 45.74 on Tuesday. Acadia Healthcare Company, Inc. has a 52-week low of $32.54 and a 52-week high of $54.34. The firm has a market cap of $4.02 billion, a PE ratio of 502.64 and a beta of 1.14. The company’s 50 day moving average price is $48.76 and its 200 day moving average price is $45.93.

Acadia Healthcare (NASDAQ:ACHC) last issued its earnings results on Thursday, July 27th. The company reported $0.66 earnings per share (EPS) for the quarter, beating the Thomson Reuters’ consensus estimate of $0.65 by $0.01. Acadia Healthcare had a net margin of 0.30% and a return on equity of 8.69%. The business had revenue of $715.90 million during the quarter, compared to the consensus estimate of $717.38 million. During the same period last year, the business posted $0.73 EPS. Acadia Healthcare’s revenue was down 5.4% on a year-over-year basis. Analysts predict that Acadia Healthcare Company, Inc. will post $2.45 earnings per share for the current fiscal year.

In other Acadia Healthcare news, Director Reeve B. Waud sold 50,000 shares of the firm’s stock in a transaction that occurred on Thursday, June 22nd. The shares were sold at an average price of $47.51, for a total transaction of $2,375,500.00. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website. Also, Director William Grieco sold 2,000 shares of the firm’s stock in a transaction that occurred on Friday, August 11th. The stock was sold at an average price of $51.71, for a total transaction of $103,420.00. Following the sale, the director now owns 45,013 shares of the company’s stock, valued at $2,327,622.23. The disclosure for this sale can be found here. Insiders have sold 3,185,693 shares of company stock valued at $162,606,599 over the last 90 days. Company insiders own 11.10% of the company’s stock.

COPYRIGHT VIOLATION WARNING: This article was published by Daily Political and is the property of of Daily Political. If you are accessing this article on another domain, it was stolen and republished in violation of U.S. and international trademark & copyright legislation. The correct version of this article can be accessed at https://www.dailypolitical.com/2017/09/19/312345-shares-in-acadia-healthcare-company-inc-achc-purchased-by-principal-financial-group-inc.html.

ACHC has been the subject of a number of analyst reports. William Blair initiated coverage on Acadia Healthcare in a research report on Tuesday, July 18th. They issued an “outperform” rating for the company. Jefferies Group LLC set a $55.00 price target on Acadia Healthcare and gave the stock a “buy” rating in a research report on Thursday, June 1st. KeyCorp reaffirmed an “overweight” rating and issued a $51.00 price target on shares of Acadia Healthcare in a research report on Thursday, June 1st. BidaskClub raised Acadia Healthcare from a “hold” rating to a “buy” rating in a research report on Saturday, July 1st. Finally, Zacks Investment Research raised Acadia Healthcare from a “hold” rating to a “buy” rating and set a $53.00 price target for the company in a research report on Wednesday, June 28th. One investment analyst has rated the stock with a sell rating, four have issued a hold rating, nine have given a buy rating and one has assigned a strong buy rating to the stock. The stock currently has a consensus rating of “Buy” and an average price target of $58.69.

About Acadia Healthcare

Acadia Healthcare Company, Inc is a provider of behavioral healthcare services, with operations in the United States and the United Kingdom. The Company focuses on acquiring and developing behavioral healthcare facilities. The Company operates through two segments: U.S. Facilities and U.K. Facilities.

Institutional Ownership by Quarter for Acadia Healthcare (NASDAQ:ACHC)

Receive News & Ratings for Acadia Healthcare Company Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Acadia Healthcare Company Inc. and related companies with MarketBeat.com's FREE daily email newsletter.